Two Seas Capital »

Lucid Diagnostics shares owned by Two Seas Capital

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 3.0M 1.01

More positions owned by Two Seas Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Core Scientific (CORZ)
Indivior Ord (INDV)
Roivant Sciences SHS (ROIV)
Coreweave Com Cl A (CRWV)
Calumet (CLMT)
Talen Energy Corp (TLN)
Avadel Pharmaceuticals Com Shs (AVDL)
First Solar (FSLR)
Gannett (GCI)
Sotera Health (SHC)
Arbutus Biopharma (ABUS)
Ftai Aviation SHS (FTAI)
Immunovant (IMVT)

View all positions for Two Seas Capital

Top funds holding Lucid Diagnostics

Vanguard Group
Masters Capital Mgmt
BlackRock
Two Seas Capital
AWM Investment Company
Ghisallo Capital Management
Standard Life Aberdeen
Geode Capital Management
Alyeska Investment Group
Perkins Capital Management
State Street Corporation
Luminus Management
Wells Fargo & Company
Goldman Sachs Group
Northern Trust

View all funds holding Lucid Diagnostics